Manipulating the epigenome for the treatment of urological malignancies. - Wikidata - wikimedia - TriplyDB

Manipulating the epigenome for the treatment of urological malignancies.

Manipulating the epigenome for the treatment of urological malignancies.

http://www.wikidata.org/entity/Q37524412

about

The role of epigenetics in kidney malignancies Epigenetics of Renal Development and Disease Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.Alterations of DNA methylome in human bladder cancer.Current Concepts of Epigenetics in Testicular Cancer.Targeting DNA Methyltranferases in Urological Tumors.

P2860

Q26801233-1CE81581-B7DD-4B01-A188-90AC37764046 Q28079434-701615BC-5D3A-4A62-9486-F12E05CBD995 Q33668999-F8995CC7-A540-44C2-9410-1F67F2A41DDA Q34733206-0889DD42-6F99-4BDC-93AE-9A4172B5A441 Q36893027-C7EC9D23-06E4-4F33-B834-05902717CE40 Q38131409-11FC5F52-0754-4F42-A8E2-999C89D1380A Q39331536-CC6C8A34-F9FC-4633-AECE-EF9ED7182B17 Q55435258-DDAA7CDA-52C9-4BF2-B92C-394330AB60A0

P2860

Manipulating the epigenome for the treatment of urological malignancies.

http://www.wikidata.org/entity/Q37524412

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Manipulating the epigenome for the treatment of urological malignancies.

@en

Manipulating the epigenome for the treatment of urological malignancies.

@nl

type

label

Manipulating the epigenome for the treatment of urological malignancies.

@en

Manipulating the epigenome for the treatment of urological malignancies.

@nl

prefLabel

Manipulating the epigenome for the treatment of urological malignancies.

@en

Manipulating the epigenome for the treatment of urological malignancies.

@nl

P1433

Q37524412-7C374695-50AF-49E8-BAB7-373A9DA436D3

P1476

Q37524412-E9388976-67ED-4455-8C35-D7B50241E0DF

P2093

Q37524412-3BAF99A3-9EDE-4401-8416-372AC52E1EF5

Q37524412-46D8B53E-D0E3-44A8-899E-858D9F90994D

Q37524412-60DC57BA-BFDC-4A88-9172-89A865AC249B

Q37524412-9B071226-8FE4-49CA-85A0-8BEB31196848

Q37524412-9FAABD41-D078-421F-8EC2-2E3BC0984207

Q37524412-C62CC047-C662-43AE-87BE-E6395117E447

Q37524412-CB26034F-2CCD-4D21-90D3-3E1F4796A535

P2860

Q37524412-05788D15-1EAF-4D98-BDA8-5899479F1FBE

Q37524412-0988B525-968F-4A6A-9A41-20200E02D998

Q37524412-09AB1D08-BA28-4E90-A12F-9EBC4DC96F33

Q37524412-0A81B0DB-3036-424F-A3C1-E28F00AF1BA4

Q37524412-0C3BA37A-44A6-4031-AF64-41934F593074

Q37524412-0C77FB77-BAE4-4723-82F8-C516CC91A7D0

Q37524412-0D370625-3473-4819-BDCD-EA9792C467C8

Q37524412-0DC3B69A-7FC5-4B08-BA26-38A15727993A

Q37524412-10B58698-FE41-4105-9870-24AD3873EE8D

Q37524412-13B1B0D3-5481-4C4E-BC34-F5A52D624081

P304

Q37524412-AA2C901E-60C8-49A2-91C1-AA7E619DA9BC

P31

Q37524412-8A7AD596-2C55-4764-98B2-D1D891F958C6

P356

Q37524412-8EA674D6-1E1D-413A-9C2D-5385933AF6CB

P433

Q37524412-07A91B29-7AAD-413C-9D3A-926C02440D50

P478

Q37524412-FA7241D4-4E70-40E0-84A5-C53363A613FE

P50

Q37524412-497ACCF4-72AE-495A-AE00-B6E995FAB074

P577

Q37524412-85C65E81-3F76-4DDA-A728-2FC687B3D750

P698

Q37524412-8D3851F3-FD48-48D5-83D4-C53167C68504

P932

Q37524412-3AC284BE-68DE-4506-AB57-86971500BD3F

P356

J.PHARMTHERA.2013.01.007

P1433

Pharmacology & Therapeutics

P1476

Manipulating the epigenome for the treatment of urological malignancies.

@en

P2093

Antoinette S Perry

http://www.w3.org/2001/XMLSchema#string

Colm J O'Rourke

http://www.w3.org/2001/XMLSchema#string

Diarmaid Moran

http://www.w3.org/2001/XMLSchema#string

Donal Hollywood

http://www.w3.org/2001/XMLSchema#string

Eva Bolton

http://www.w3.org/2001/XMLSchema#string

Thomas Lynch

http://www.w3.org/2001/XMLSchema#string

Vinicius Knabben

http://www.w3.org/2001/XMLSchema#string

P2860

The emerging role of histone lysine demethylases in prostate cancer

Hallmarks of Cancer: The Next Generation

p53 is regulated by the lysine demethylase LSD1

Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression

The Polycomb group protein EZH2 directly controls DNA methylation

Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer

LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

Human DNA methylomes at base resolution show widespread epigenomic differences

High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer

P304

185-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHARMTHERA.2013.01.007

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Vinicius Knabben

P577

2013-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23353098

http://www.w3.org/2001/XMLSchema#string

P932

5176100

http://www.w3.org/2001/XMLSchema#string